The dramatic amount of weight that study volunteers lost on the new drug exceeds the percentage of weight most people lose when they use the popular weight-loss drugs, Wegovy and Zepbound
"Dong-A ST's DPP4 inhibitor, SUGANON, got approved for type 2 diabetes in Korea"
Third-party data: Some pharmacies rely on stability data from ingredient suppliers or third-party laboratories
Mounjaro was introduced first and is FDA approved to help people with type 2 diabetes manage blood sugar
The company is already on track to meet or exceed my base case revenue expectations and Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win Summary Eli Lilly continues strong execution, exceeding revenue expectations and expanding its pipeline with strategic, low-risk acquisitions in infectious diseases and other areas
side effect severity is not within personal control